Liquid Crystals News
-
The next drug approval for Merck KGaA, Germany’s second-biggest drugmaker, probably won’t come until 2016, more than a decade after the blockbuster cancer treatment Erbitux reached the market.
-
Merck KGaA shares rose to a record after the German maker of cancer drug Erbitux forecast higher profit in 2013 and 2014 as accelerated cost cuts helped fourth- quarter profit beat analysts’ estimates.
-
Merck KGaA is developing liquid crystals for 3-D televisions that don’t require special glasses as the company seeks to bolster sales of the fastest-growing use for the product.
-
Merck KGaA said first-quarter profit more than tripled as demand returned for the liquid crystals it makes for flat-panel televisions and monitors. The company raised its 2010 forecast.
-
Merck KGaA third-quarter profit rose 46 percent as the company reported revenue from this year’s $6 billion acquisition of U.S. biotechnology equipment supplier Millipore Corp. for the first time.
-
Merck KGaA, the German maker of the cancer drug Erbitux, reported third-quarter profit that exceeded analyst estimates and increased the full-year sales forecast on higher demand for its medicines.
-
Sony Corp. , the world’s third- largest television maker, and Taiwan’s Chimei Innolux Corp. settled their legal dispute over patents on liquid-crystal display TVs and monitors, U.S. court records show.
-
Allstate Corp. sued Bank of America Corp. and its Countrywide mortgage unit over $700 million in residential mortgage-backed securities the insurer purchased, claiming Countrywide misrepresented the investments.
-
Merck KGaA said first-quarter profit rose 78 percent as last year’s acquisition of U.S. biotechnology equipment supplier Millipore Corp. boosted sales.
-
German stocks fell, with the benchmark DAX Index headed for its second consecutive weekly loss, led by drops in HeidelbergCement AG and carmakers.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page